Ocugen to co-develop Bharat Biotech's Covid-19 vaccine candidate for US
The vaccine candidate, Covaxin, is currently in a late-stage study in India
Drug developer Ocugen Inc will co-develop India-based Bharat Biotech's Covid-19 vaccine candidate for the US market, the companies said on Tuesday.
The vaccine candidate, Covaxin, is currently in a late-stage study in India.